Rare diseases
Investigational molecules
Locations
Back to the Netherlands150 clinical trials in S-Hertogenbosch, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)The NetherlandsStudy on the Effects of ALZ-801 in Patients Aged 50-80 with Early Alzheimer's Disease and APOE4 Genotype
The NetherlandsStudy of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation
The NetherlandsStudy Comparing Two Treatment Sequences of CDK4/6 Inhibitors (Abemaciclib, Palbociclib, or Ribociclib) in Hormone Receptor Positive Advanced Breast Cancer
The NetherlandsStudy of Trastuzumab, Pertuzumab, and Chemotherapy Combination with Response-Guided Treatment for Patients with HER2-Positive Breast Cancer
The NetherlandsStudy on Bepranemab for Patients with Early Alzheimer's Disease
The NetherlandsStudy on Dapagliflozin for Patients with Severe Chronic Kidney Disease to Improve Kidney and Heart Health Outcomes
The NetherlandsStudy of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
The NetherlandsStudy on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer's Disease
The NetherlandsStudy on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
The NetherlandsStudy on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease
The NetherlandsStudy on AVP-786 for Treating Agitation in Alzheimer's Dementia Patients
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on acute myeloid leukemia and chronic lymphocytic leukemia, evaluating innovative combination therapies and treatment approaches. Studies also include investigations into advanced breast cancer treatments and novel therapies for small cell lung cancer.
Several trials are exploring targeted therapies and immunotherapy combinations to improve patient outcomes.
Research initiatives examining heart failure prevention and stroke management, including studies on new therapeutic combinations and preventive treatments for cardiovascular events.
Focus on developing innovative treatments to reduce cardiovascular mortality and improve patient outcomes.
Clinical investigations targeting Alzheimer's disease, evaluating new therapeutic approaches for both mild cognitive impairment and dementia. Studies aim to improve cognitive function and quality of life.
Trials explore novel drug combinations and treatment strategies for neurodegenerative conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
